Read more
In the era of personalized medicine, cancer treatment has become a model for the use of targeted therapeutics. Leaving behind the "one size fits all" approach to cancer care, this book provides the practicing oncologist with an overview of the advances in treatment and an understanding of the implementation of new therapeutic agents. Targeted Cancer Therapy is divided into twenty chapters covering specific hematologic malignancies and solid tumors, targeted and functional imaging, and combination therapies. Each disease specific chapter includes up-to-date information on investigational and FDA approved therapies which will enhance the reader's ability to prescribe effective drug regimens. This includes combinations of therapies and therapeutic modalities to overcome drug resistance.
In a rapidly changing field, this book will enable clinicians to improve their ability to practice personalized health planning, make early diagnoses, and select optimal drugs for each patient with predictable side effects and outcomes. Poised to change the landscape in oncology, Targeted Cancer Therapy is essential for practicing and academic physicians, fellows, and residents.
List of contents
Perspectives: Bench to Bedside and Back.- Targeted Therapy in Acute Myelogenous Leukemia.- Targeted Therapy in Breast Cancer.- Targeted Therapy in Chronic Lymphocytic Leukemia.- Targeted Therapy in Chronic Myeloid Leukemia.- Targeted Therapy in Colorectal Cancer.- Targeted Therapy in Non-Small Cell Lung Cancer.- Targeted Therapy in Lymphoma.- Targeted Therapy in Melanoma.- Targeted Therapy in Multiple Myeloma.- Targeted Therapy in Myelodysplastic Syndrome.- Targeted Therapy in Epithelial Ovarian Cancer.- Targeted Drug Therapy in Pancreatic Cancer.- Targeted Therapy in Prostate Cancer.- Targeted Therapy in Renal Cell Carcinoma.- Targeted Therapy of Sarcoma.- Targeted and Functional Imaging.- Combining Targeted Therapies.- Drug Development in Cancer Medicine: Challenges for Targeted Approaches.- Toward Personalized Therapy for Cancer.
Summary
In the era of personalized medicine, cancer treatment has become a model for the use of targeted therapeutics. Leaving behind the "one size fits all" approach to cancer care, this book provides the practicing oncologist with an overview of the advances in treatment and an understanding of the implementation of new therapeutic agents. Targeted Cancer Therapy is divided into twenty chapters covering specific hematologic malignancies and solid tumors, targeted and functional imaging, and combination therapies. Each disease specific chapter includes up-to-date information on investigational and FDA approved therapies which will enhance the reader’s ability to prescribe effective drug regimens. This includes combinations of therapies and therapeutic modalities to overcome drug resistance.
In a rapidly changing field, this book will enable clinicians to improve their ability to practice personalized health planning, make early diagnoses, and select optimal drugs for each patient with predictable side effects and outcomes. Poised to change the landscape in oncology, Targeted Cancer Therapy is essential for practicing and academic physicians, fellows, and residents.
Additional text
From the reviews:
“Targeted Cancer Therapy provides an overview of recent advancements in therapy deriving from the implementation of new therapeutic agents. … this book represents a useful and stimulating publication. … the book has a scientific and cultural appeal for many other professionals interacting with patients with neoplastic disease. … we also suggest this volume to all students who want to grow into becoming protagonists in the new era of molecular medicine.” (Luigi Mansi and Andrea Vaccaro, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, 2012)
Report
From the reviews:
"Targeted Cancer Therapy provides an overview of recent advancements in therapy deriving from the implementation of new therapeutic agents. ... this book represents a useful and stimulating publication. ... the book has a scientific and cultural appeal for many other professionals interacting with patients with neoplastic disease. ... we also suggest this volume to all students who want to grow into becoming protagonists in the new era of molecular medicine." (Luigi Mansi and Andrea Vaccaro, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, 2012)
